MCU analysis implied that DDX6 has an antiviral role in HSV-1 infection (Fig. 4), and we observed that the mean intensity of DDX6 decreased in HSV-1-infected HeLa cells at the late stages of infection (Fig. 7a and Supplementary Fig.  14a). Here, DDX6 is linked to infection.